STUDY OF IMMUNE RESPONSE TO DNA+ RECOMBINANT PROTEIN VACCINE AGAINST RSV

RSV DNA重组蛋白疫苗免疫反应的研究

• 批准号: 7529138
• 负责人: SHREE R SINGH
• 金额: $ 21.12万
• 依托单位: ALABAMA STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-30 至 2008-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7529138
• 关键词: Adjuvant; Age-Years; Animals; Antibodies; Antigens; Biological Assay; Bronchiolitis; CD4 Positive T Lymphocytes; CD8B1 gene; Cell surface; Cells; Child; Chimeric Proteins; Chinese Hamster Ovary Cell; Cholera Toxin; DNA; DNA Recombinant Proteins; DNA Vaccines; Development; Effectiveness; Fluorescence Microscopy; Formalin; Gene Transduction Agent; Gene-Modified; Genes; Genetic Engineering; Genetic Transcription; Goals; Helper-Inducer T-Lymphocyte; Hospitalized Child; IgG1; Immune response; Immunity; Immunization; Immunoglobulin A; Immunoglobulin G; In Vitro; Interleukin-10; Interleukin-4; Interleukin-5; Lower respiratory tract structure; Lung diseases; Monoclonal Antibodies; Monoclonal Antibody HuM291; Mucosal Immune Responses; Mucous Membrane; Muromonab-CD3; Mus; Plasmids; Pneumonia; Proteins; Recombinant DNA; Recombinant Proteins; Recombinants; Research; Respiratory Syncytial Virus Vaccines; Respiratory Tract Diseases; Respiratory syncytial virus; Respiratory syncytial virus RSV F proteins; System; T-Lymphocyte; Testing; Translations; Vaccination; Vaccines; Viral; Virus; Virus Diseases; Western Blotting; cytokine; design; immunogenic; plasmid DNA; protein expression; response; vector